-
1 week ago | 
medicaldialogues.in | Nandita Mohan
This video focuses on a recent article published in the Journal Of Health and Allied Sciences published by Scientific Scholar. In the current digital era, medical journalism plays a crucial role in bridging the gap between scientific advancements and public understanding.
-
1 week ago | 
medicaldialogues.in | Nandita Mohan
A recent consensus & expert recommendations published in the Primary Care Respiratory Medicine journal has revealed insightful facts. In-hospital mortality for ECOPD varies between 2.5% and 25%, while 25-55% of survivors face readmission. A 7-point evidence-based discharge protocol can significantly lower mortality and reduce rehospitalization rates for acute exacerbations of COPD(ECOPD) if effectively implemented.
-
2 weeks ago | 
medicaldialogues.in | Nandita Mohan
To give a brief about Myeloid sarcoma (MS), it is a tumor mass formed by the collection of myeloid blasts at sites other than bone marrow. MS can occur as an isolated mass or concurrently as acute myeloid leukemia (AML) in bone marrow or in a case of myeloproliferative neoplasm/myelodysplastic neoplasm. The study aimed to highlight the varied presentation and morpho-immunohistochemistry guide to recognize this entity in biopsy for its therapeutic connotation.
-
2 weeks ago | 
medicaldialogues.in | Nandita Mohan
Total anomalous pulmonary venous connection (TAPVC) is a congenital cardiac malformation. If it is not repaired surgically, the chances of survival of the patient are meager. Due to the improved perioperative care and surgical techniques, the overall results have also improved. This study assesses the risk factors in relation to early mortality in TAPVC repairs performed over a period of 10 years by a single surgeon in our institute.
-
2 weeks ago | 
medicaldialogues.in | Nandita Mohan
Intimate partner violence (IPV) is a significant public health and human rights issue affecting all genders. IPV is overwhelmingly prevalent among women, but it is being increasingly acknowledged that men, too, are IPV victims. This study draws on the lived experiences of ever-married men to explore the various forms and effects of IPV experienced by them from their female partners within the ambit of heterosexual marriages.
-
3 weeks ago | 
medicaldialogues.in | Nandita Mohan
This article is published in the Journal of Comprehensive Health published by Scientific Scholar. Sexual health is a critical component of overall well-being, particularly among adolescents and young adults. Comprehensive sexual education (CSE) plays a vital role in promoting responsible reproductive health behaviors, preventing unintended pregnancies, and reducing sexually transmitted infections (STIs).
-
3 weeks ago | 
medicaldialogues.in | Nandita Mohan
This original article published in the Indian journal of Medical Sciences published by Scientific Scholar. The objective of the study was to evaluate and compare the impact of axillary LN dissection and sentinel lymph node biopsy on the oncological outcomes of breast cancer patients. This prospective cohort study included 160 patients with breast carcinoma who were scheduled to receive total axillary dissection.
-
1 month ago | 
medicaldialogues.in | Nandita Mohan
Biosimilar denosumab of Alkem (Denuril) showed comparable efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity to the innovator denosumab in women with postmenopausal osteoporosis, concluded in a recent study. Published in the January 2025 issue of Journal of the Association of Physicians of India. This Phase III randomized study included 177 osteoporotic postmenopausal women of 50–80 years age in a 2:1 ratio—116 to Denuril 61 to innovator denosumab.
-
1 month ago | 
medicaldialogues.in | Nandita Mohan
Pharma major Boehringer Ingelheim has announced a significant price reduction for its popular drugs, JARDIANCE® and GLYXAMBI®, making them more affordable for patients suffering from Type 2 Diabetes (T2D), Heart Failure (HF), and Chronic Kidney Disease (CKD). JARDIANCE® a globally recognised SGLT2 inhibitor, has undergone a 31% price reduction, while, GLYXAMBI®, a combination therapy for Type 2 Diabetes management, is now 25% more affordable, benefiting a broader patient population.
-
1 month ago | 
medicaldialogues.in | Nandita Mohan
Darbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced anemia (CIA) patients, results from the latest Indian retrospective study has revealed. This study has been published in the January 2025 issue of Frontiers in Oncology. Anemia is common in cancer patients, with 39% anemic at diagnosis and 13% developing it during treatment1.
